Abstract:Glycosylation is one of the most important post-translational modifications of protein. Recently, global profiling of human serum glycomics has become a noninvasive method for cancer-related biomarker discovery and many studies have focused on compositional glycan profiling. In contrast, structure-specific glycan profiling may provide more potential biomarkers with higher specificity than compositional profiling. In this work, N-glycans released from human serum were neutralized with methylamine and reduced by ammonia-borane complex prior to profiling using nanoLC-ESI-MS with porous graphitized carbon (PGC) and relative abundances of over 280 isomers were compared between pancreatic cancer (PC) cases (n = 32) and healthy controls (n = 32). Statistical analysis identified 25 specific-isomeric biomarkers with significant differences (p-value < 0.05). ROC and PCA analysis were performed to assess the potential biomarkers which were identified as being significantly altered in cancer. The AUCs of the significantly changed specific-isomers were ranging from 0.712 to 0.949. In addition, with the combination of all potential biomarkers, a higher AUC of 0.976 with sensitivity (93.5%) and specificity (90.6%) was obtained. Overall, the proposed strategy coupled to relative quantitative analysis of isomeric glycans make it possible to discover new biomarkers for the diagnosis of PC. Significance: Pancreatic cancer (PC) has a poor prognosis with a five-year survival rate < 5%. Therefore, a strategy for accurate diagnosis of PC is indeed required. In this paper, a dual-derivatized strategy for structure-specific glycan profiling has been used and according to our best knowledge, this is the first application of this strategy for PC biomarker discovery, in which the separation, identification and relative quantification of isomeric glycans can be simultaneously obtained. In addition, by in-depth analysis of isomeric glycans, the full description of the stereo- and region- diversity of glycans can also be achieved, which might provide more potential information for PC biomarker discovery.

Proteomics Analysis of Serum Protein Profiling in Pancreatic Cancer Patients by DIGE: Up-Regulation of Mannose-Binding Lectin 2 and Myosin Light Chain Kinase 2

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Serum Proteomic-Based Analysis of Pancreatic Carcinoma for the Identification of Potential Cancer Biomarkers.

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

Proteomic Identification of Serum Biomarkers for Gastric Cancer Using Multi-Dimensional Liquid Chromatography and 2d Differential Gel Electrophoresis

Separation and Identification of Differentially Expressed Proteins in Pancreatic Carcinoma by Two-Dimen-sional Gel Electrophoresis and Mass Spectrometry

Proteome Analysis of Human Pancreatic Ductal Adenocarcinoma Tissue Using Two-Dimensional Gel Electrophoresis and Tandem Mass Spectrometry for Identification of Disease-Related Proteins

Differential Expressed Profile of Proteins in Normal Tissue and Pancreatic Cancer Using Proteomic Approaches

Differential analysis of two-dimensional gel electrophoresis profile of pancreatic ductal adenocarcinoma and adjacent tissue

Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics Analysis

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

Isomer-specific Profiling of N-glycans Derived from Human Serum for Potential Biomarker Discovery in Pancreatic Cancer

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

Serological Biomarker Identification in Gastric Cancer by Two-Dimensional Differential In-Gel Electro-Phoresis

Screening and Identification of Differential Expression Proteins from Pancreatic Carcinoma and Neighboring Normal Pancreatic Tissues

Profiling Pancreatic Cancer-Secreted Proteome Using 15N Amino Acids and Serum-Free Media

Serum N-Glycome analysis reveals pancreatic cancer disease signatures

Searching for Serum Tumor Markers for Colorectal Cancer Using a 2‐D DIGE Approach

MALDI-TOF-MS Analysis in the Discovery and Identification of the Serum Peptide Pattern of Pancreatic Ductal Adenocarcinoma